Trial Profile
A Prospective, Double Blind, Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Antroquinonol (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Golden Biotechnology Corporation
- 12 May 2019 Status changed from active, no longer recruiting to completed.
- 27 Jan 2019 Planned End Date changed from 30 Sep 2018 to 31 Mar 2019.
- 31 Jul 2018 Planned End Date changed from 1 Jun 2018 to 30 Sep 2018.